ABSTRACT
Background Studies have shown that periodontal and periapical diseases are more prevalent among diabetes mellitus (DM) patients. Here, we evaluated the potential relationship between endodontic pathologies and DM through a retrospective analysis of 2,000 electronic health records (EHR) of individuals with/without DM.
Methods Records of patients treated at UTHealth School of Dentistry presenting with a history of endodontic treatment with and without DM were randomly selected for analysis of 24 treatment- and patient-centric variables to assess for the association between endodontic disease and DM. Data between groups were compared using Chi-square, Fisher Exact tests, and one-way analysis of variance (ANOVA). Significant differences were set at P<0.05.
Results Diabetic patients had significantly less symptomatic pulpal diagnoses, particularly less symptomatic irreversible pulpitis (P<0.00005); whereas they had significantly more symptomatic apical periodontitis (P=0.01) than non-diabetics. Diabetics had a significantly greater number of endodontically-treated teeth (P=2.2 × 10−16), particularly canines and molars (P<0.002). The frequency of active periapical lesions was higher in non-diabetics, although no differences in lesion size were observed. The frequency of periodontal disease and additional systemic disease(s), and smoking was significantly increased in DM patients with endodontic treatment (P<0.05). No differences were observed between the number of medications taken between groups or upon stratifying analysis by gender (P>0.05).
Conclusions Our results continue to support that DM contributes to increased endodontic disease and highlight the complex relationships between oral and systemic diseases.
Practical Implications Dental professionals should be cognizant of endodontic pathology as a clinical complication of DM that presents as more chronic in nature, at a greater frequency, and have a tendency toward a nonhealing outcome.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the UTHealth Committee for Protection of Human Subjects gave ethical approval for this work(HSC-DB-17-0565).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript